Mulligan AM - Search Results

1

EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.

Bane AL, Mulligan AM, Pinnaduwage D, O'Malley FP, Andrulis IL. Bane AL, et al. Among authors: mulligan am. Breast Cancer Res Treat. 2011 Jun;127(3):831-9. doi: 10.1007/s10549-011-1380-y. Epub 2011 Feb 15. Breast Cancer Res Treat. 2011. PMID: 21327470

2

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.

Mulligan AM, O'Malley FP, Ennis M, Fantus IG, Goodwin PJ. Mulligan AM, et al. Breast Cancer Res Treat. 2007 Nov;106(1):39-47. doi: 10.1007/s10549-006-9471-x. Epub 2007 Jan 13. Breast Cancer Res Treat. 2007. PMID: 17221153

3

Papillary lesions of the breast: a review.

Mulligan AM, O'Malley FP. Mulligan AM, et al. Adv Anat Pathol. 2007 Mar;14(2):108-19. doi: 10.1097/PAP.0b013e318032508d. Adv Anat Pathol. 2007. PMID: 17471117 Review.

4

Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases.

Mulligan AM, O'Malley FP. Mulligan AM, et al. Int J Surg Pathol. 2007 Apr;15(2):143-7. doi: 10.1177/1066896906299119. Int J Surg Pathol. 2007. PMID: 17478767

5

High-level JAG1 mRNA and protein predict poor outcome in breast cancer.

Dickson BC, Mulligan AM, Zhang H, Lockwood G, O'Malley FP, Egan SE, Reedijk M. Dickson BC, et al. Among authors: mulligan am. Mod Pathol. 2007 Jun;20(6):685-93. doi: 10.1038/modpathol.3800785. Mod Pathol. 2007. PMID: 17507991 Free article.

6

PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.

Ni R, Mulligan AM, Have C, O'Malley FP. Ni R, et al. Among authors: mulligan am. Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):316-24. doi: 10.1097/01.pai.0000213138.01536.2e. Appl Immunohistochem Mol Morphol. 2007. PMID: 17721278

7

Granular cell tumour of the breast: MRI findings and review of the literature.

Scaranelo AM, Bukhanov K, Crystal P, Mulligan AM, O'Malley FP. Scaranelo AM, et al. Among authors: mulligan am. Br J Radiol. 2007 Dec;80(960):970-4. doi: 10.1259/bjr/95130566. Epub 2007 Oct 16. Br J Radiol. 2007. PMID: 17940129

8

JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.

Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE, Andrulis IL. Reedijk M, et al. Among authors: mulligan am. Breast Cancer Res Treat. 2008 Oct;111(3):439-48. doi: 10.1007/s10549-007-9805-3. Epub 2007 Nov 8. Breast Cancer Res Treat. 2008. PMID: 17990101

9

Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort.

Mulligan AM, Pinnaduwage D, Bull SB, O'Malley FP, Andrulis IL. Mulligan AM, et al. Clin Cancer Res. 2008 Jul 1;14(13):4168-74. doi: 10.1158/1078-0432.CCR-07-4543. Clin Cancer Res. 2008. PMID: 18593996

10

Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.

Broom RJ, Tang PA, Simmons C, Bordeleau L, Mulligan AM, O'Malley FP, Miller N, Andrulis IL, Brenner DM, Clemons MJ. Broom RJ, et al. Among authors: mulligan am. Anticancer Res. 2009 May;29(5):1557-62. Anticancer Res. 2009. PMID: 19443366 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters